$ZUMZ
Zumiez Inc

2020 Q2 Form 10-Q Financial Statement

#000156459020028612 Filed on June 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $137.8M $212.9M
YoY Change -35.29% 3.21%
Cost Of Revenue $114.0M $146.5M
YoY Change -22.14% 1.92%
Gross Profit $23.74M $66.46M
YoY Change -64.29% 6.19%
Gross Profit Margin 17.23% 31.22%
Selling, General & Admin $51.58M $65.50M
YoY Change -21.24% 1.87%
% of Gross Profit 217.32% 98.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.096M $6.263M
YoY Change -2.67% -10.14%
% of Gross Profit 25.68% 9.42%
Operating Expenses $51.58M $65.50M
YoY Change -21.24% 1.87%
Operating Profit -$27.85M $968.0K
YoY Change -2976.86% -156.64%
Interest Expense $1.074M $852.0K
YoY Change 26.06% 201.06%
% of Operating Profit 88.02%
Other Income/Expense, Net $106.0K $153.0K
YoY Change -30.72% -131.74%
Pretax Income -$26.67M $1.973M
YoY Change -1451.65% -203.41%
Income Tax -$5.600M $1.200M
% Of Pretax Income 60.82%
Net Earnings -$21.10M $800.0K
YoY Change -2737.63% -130.69%
Net Earnings / Revenue -15.32% 0.38%
Basic Earnings Per Share -$0.84
Diluted Earnings Per Share -$0.84 $0.03
COMMON SHARES
Basic Shares Outstanding 25.04M
Diluted Shares Outstanding 25.04M

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $217.2M $168.0M
YoY Change 29.29% 42.37%
Cash & Equivalents $70.25M $60.62M
Short-Term Investments $156.1M $112.4M
Other Short-Term Assets $5.200M $9.600M
YoY Change -45.83% -30.94%
Inventory $136.4M $136.0M
Prepaid Expenses
Receivables $16.80M $15.10M
Other Receivables $0.00 $0.00
Total Short-Term Assets $375.6M $328.6M
YoY Change 14.3% 17.95%
LONG-TERM ASSETS
Property, Plant & Equipment $395.0M $418.8M
YoY Change -5.68% 232.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $19.80M $14.80M
YoY Change 33.78% 43.69%
Total Long-Term Assets $485.8M $506.1M
YoY Change -4.01% 137.49%
TOTAL ASSETS
Total Short-Term Assets $375.6M $328.6M
Total Long-Term Assets $485.8M $506.1M
Total Assets $861.4M $834.7M
YoY Change 3.2% 69.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $49.50M $54.50M
YoY Change -9.17% 18.48%
Accrued Expenses $83.80M $69.80M
YoY Change 20.06% 362.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $156.9M $144.0M
YoY Change 8.96% 51.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $273.4M $296.8M
YoY Change -7.88% 574.55%
Total Long-Term Liabilities $273.4M $296.8M
YoY Change -7.88% 574.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $156.9M $144.0M
Total Long-Term Liabilities $273.4M $296.8M
Total Liabilities $430.3M $440.8M
YoY Change -2.38% 216.67%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $431.2M $394.0M
YoY Change
Total Liabilities & Shareholders Equity $861.4M $834.7M
YoY Change 3.2% 69.76%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$21.10M $800.0K
YoY Change -2737.63% -130.69%
Depreciation, Depletion And Amortization $6.096M $6.263M
YoY Change -2.67% -10.14%
Cash From Operating Activities -$17.54M $9.862M
YoY Change -277.87% -353.39%
INVESTING ACTIVITIES
Capital Expenditures $2.504M $3.331M
YoY Change -24.83% -7.09%
Acquisitions
YoY Change
Other Investing Activities $45.20M $5.600M
YoY Change 707.14% -35.63%
Cash From Investing Activities $42.73M $2.285M
YoY Change 1770.2% -54.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $13.42M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.08M 345.0K
YoY Change -3891.88% -92.02%
NET CHANGE
Cash From Operating Activities -17.54M 9.862M
Cash From Investing Activities 42.73M 2.285M
Cash From Financing Activities -13.08M 345.0K
Net Change In Cash 11.26M 12.03M
YoY Change -6.39% 140.14%
FREE CASH FLOW
Cash From Operating Activities -$17.54M $9.862M
Capital Expenditures $2.504M $3.331M
Free Cash Flow -$20.05M $6.531M
YoY Change -406.94% -187.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23406000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66297000
CY2020Q2 zumz Decrease In Revenue Due To Change In Foreign Exchange Rates
DecreaseInRevenueDueToChangeInForeignExchangeRates
1000000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5681000
CY2020Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4686000
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
284717000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
466086000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3745000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25828000
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
161458000
CY2020Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
288462000
CY2020Q1 us-gaap Liabilities
Liabilities
448172000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12591000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
914258000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25828000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
317219000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
21784000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
61800000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
159710000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
968000
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1074000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
106000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26668000
CY2019Q2 us-gaap Gross Profit
GrossProfit
66464000
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2020Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
152484000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6517000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70248000
CY2020Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
63731000
CY2020Q2 us-gaap Gross Profit
GrossProfit
23736000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51584000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
65496000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27848000
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
852000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
153000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1973000
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
13417000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
400456000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
345000
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6096000
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6263000
CY2020Q2 zumz Noncash Lease Expense
NoncashLeaseExpense
14996000
CY2019Q2 zumz Noncash Lease Expense
NoncashLeaseExpense
13371000
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4856000
CY2019Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1249000
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1556000
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1693000
CY2020Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1514000
CY2019Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
123000
CY2020Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
173000
CY2019Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-101000
CY2020Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1918000
CY2019Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-4708000
CY2020Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2031000
CY2019Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7540000
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4354000
CY2019Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
167000
CY2020Q2 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1074000
CY2019Q2 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
19568000
CY2020Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-10423000
CY2019Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5636000
CY2020Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1078000
CY2019Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-7104000
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
6948000
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
13770000
CY2020Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2440000
CY2019Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3790000
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17542000
CY2019Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9862000
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2504000
CY2019Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3331000
CY2020Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
9106000
CY2019Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
33385000
CY2020Q2 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
54344000
CY2019Q2 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
39001000
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
42734000
CY2019Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2285000
CY2020Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
428000
CY2019Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
583000
CY2020Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
93000
CY2019Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
238000
CY2020Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
13417000
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13082000
CY2019Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
345000
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-853000
CY2019Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-466000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11257000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12026000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58991000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54271000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
70248000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66297000
CY2020Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
343000
CY2019Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
7038000
CY2020Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1976000
CY2019Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1583000
CY2020Q2 us-gaap Fiscal Period
FiscalPeriod
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Fiscal Year&#8212;<font style="font-weight:normal;">We use a fiscal calendar widely used by the retail industry that results in a fiscal year consisting of a 52- or 53-week period ending on the Saturday closest to January&#160;31.&nbsp;&nbsp;Each fiscal year consists of four 13-week quarters, with an extra week added to the fourth quarter every five or six years.&nbsp;&nbsp;The three months ended May 2, 2020 and May 4, 2019 were 13-week periods.&nbsp;&nbsp;</font></p>
CY2020Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates&#8212;<font style="font-weight:normal;">The preparation of financial statements in conformity with U.S. GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements as well as the reported amounts of revenues and expenses during the reporting period.&nbsp;&nbsp;These estimates can also affect supplemental information disclosed by us, including information about contingencies, risk and financial condition.&nbsp;&nbsp;Actual results could differ from these estimates and assumptions.</font></p>
CY2020Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassification&#8212;<font style="font-weight:normal;">Certain prior period restricted cash amounts have been reclassified to be consistent with current year presentation within our consolidated statement of cash flows.</font></p>
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1849000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58991000
CY2020Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
153494000
CY2020Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1470000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54271000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60616000
CY2020Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1517000
CY2020Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
197300000
CY2020Q2 us-gaap Number Of Stores
NumberOfStores
719
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6563000
CY2020Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
52428000
CY2020Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2000
CY2020Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
198768000
CY2020Q2 zumz Marketable Securities Maximum Maturity Period
MarketableSecuritiesMaximumMaturityPeriod
P5Y
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
29824000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
29824000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
507000
CY2020Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
507000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
567000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
567000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2000
CY2020Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
2000
CY2020Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2019Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.033
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
17953000
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
17082000
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
676000
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
894000
CY2020Q2 us-gaap Lease Cost
LeaseCost
18629000
CY2019Q2 us-gaap Lease Cost
LeaseCost
17976000
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2214000
CY2019Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
20296000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
61945000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
72657000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
63948000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
53603000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
46058000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
73943000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
372154000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
31962000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
340192000
CY2020Q2 us-gaap Purchase Obligation
PurchaseObligation
177500000
CY2020Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
2100000
CY2020Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
1900000
CY2020Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
694000
CY2020Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
19.31
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9224000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12275000
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
12200000
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
261000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000
CY2019Q2 zumz Increase Decrease In Sales
IncreaseDecreaseInSales
24300000
CY2019Q2 zumz Percentage Of Increase Decrease In Sales
PercentageOfIncreaseDecreaseInSales
0.796

Files In Submission

Name View Source Status
0001564590-20-028612-index-headers.html Edgar Link pending
0001564590-20-028612-index.html Edgar Link pending
0001564590-20-028612.txt Edgar Link pending
0001564590-20-028612-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zumz-10q_20200502.htm Edgar Link pending
zumz-20200502.xml Edgar Link completed
zumz-20200502.xsd Edgar Link pending
zumz-20200502_cal.xml Edgar Link unprocessable
zumz-20200502_def.xml Edgar Link unprocessable
zumz-20200502_lab.xml Edgar Link unprocessable
zumz-20200502_pre.xml Edgar Link unprocessable
zumz-ex311_6.htm Edgar Link pending
zumz-ex312_8.htm Edgar Link pending
zumz-ex321_7.htm Edgar Link pending